BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23592522)

  • 21. Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.
    Chiche A; Moumen M; Petit V; Jonkers J; Medina D; Deugnier MA; Faraldo MM; Glukhova MA
    Stem Cells; 2013 Sep; 31(9):1857-67. PubMed ID: 23712598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.
    Li H; Cherukuri P; Li N; Cowling V; Spinella M; Cole M; Godwin AK; Wells W; DiRenzo J
    Cancer Res; 2007 Jan; 67(2):501-10. PubMed ID: 17234757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells.
    Bisaro B; Montani M; Konstantinidou G; Marchini C; Pietrella L; Iezzi M; Galiè M; Orso F; Camporeale A; Colombo SM; Di Stefano P; Tornillo G; Camacho-Leal MP; Turco E; Taverna D; Cabodi S; Amici A; Defilippi P
    Breast Cancer Res; 2012 Oct; 14(5):R137. PubMed ID: 23098208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy.
    Kuonen F; Laurent J; Secondini C; Lorusso G; Stehle JC; Rausch T; Faes-Van't Hull E; Bieler G; Alghisi GC; Schwendener R; Andrejevic-Blant S; Mirimanoff RO; Rüegg C
    Clin Cancer Res; 2012 Aug; 18(16):4365-74. PubMed ID: 22711708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.
    Kurpios NA; MacNeil L; Shepherd TG; Gludish DW; Giacomelli AO; Hassell JA
    Dev Biol; 2009 Jan; 325(1):106-21. PubMed ID: 18977342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p130Cas-dependent actin remodelling regulates myogenic differentiation.
    Kawauchi K; Tan WW; Araki K; Abu Bakar FB; Kim M; Fujita H; Hirata H; Sawada Y
    Biochem J; 2012 Aug; 445(3):323-32. PubMed ID: 22587391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
    Sampayo R; Recouvreux S; Simian M
    Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
    Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
    Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
    Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage.
    Lindley LE; Curtis KM; Sanchez-Mejias A; Rieger ME; Robbins DJ; Briegel KJ
    Development; 2015 Mar; 142(5):893-904. PubMed ID: 25655704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis.
    Farabaugh SM; Litzenburger BC; Elangovan A; Pecar G; Walheim L; Atkinson JM; Lee AV
    Dev Biol; 2020 Jul; 463(1):77-87. PubMed ID: 32376245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
    Ling H; Sylvestre JR; Jolicoeur P
    Oncogene; 2010 Aug; 29(32):4543-54. PubMed ID: 20562911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
    Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE
    Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Bonetti P; Climent M; Panebianco F; Tordonato C; Santoro A; Marzi MJ; Pelicci PG; Ventura A; Nicassio F
    Oncogene; 2019 Jan; 38(3):360-374. PubMed ID: 30093634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer.
    Steenbrugge J; Breyne K; Denies S; Dekimpe M; Demeyere K; De Wever O; Vermeulen P; Van Laere S; Sanders NN; Meyer E
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):113-122. PubMed ID: 27714576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells.
    Cabodi S; Moro L; Baj G; Smeriglio M; Di Stefano P; Gippone S; Surico N; Silengo L; Turco E; Tarone G; Defilippi P
    J Cell Sci; 2004 Mar; 117(Pt 8):1603-11. PubMed ID: 15020686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
    Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.